Medical Condition News

RSS

Encouraging results from OptiNose's sumatriptan Phase II study for migraine

OptiNose, a leader in nasal drug delivery systems, is pleased to announce the publication in Cephalalgia of results from its Phase II clinical study investigating the efficacy and tolerability of its novel, intranasal drug/device product for the treatment of migraine.

8 Apr 2010

Oraya Therapeutics' IRay stereotactic radiotherapy system granted European CE Mark approval

Oraya Therapeutics, Inc. announces today that a leading European notified body has granted approval to designate the CE mark to Oraya's IRayTM stereotactic radiotherapy system. Under development since 2007, the IRay is designed specifically to treat diseases of the eye, and the technology enables precise delivery of low energy X-rays for the treatment of wet age-related macular degeneration (AMD).

8 Apr 2010

Ultrasound scan of carotid artery improves prediction of heart disease: Research

New research shows that doing a simple ultrasound scan of the carotid artery significantly improves the prediction of heart disease, giving doctors a better clue of who is at high risk for a heart attack.

8 Apr 2010

MAP Pharmaceuticals initiates PD trial comparing LEVADEX to IV DHE

MAP Pharmaceuticals, Inc. today announced that the Company initiated a pharmacodynamics (PD) trial to compare the acute effect of LEVADEX™ orally inhaled migraine therapy to intravenous dihydroergotamine mesylate (IV DHE) and placebo on pulmonary artery pressure as measured by echocardiography.

8 Apr 2010

Avid Radiopharmaceuticals, PETNET Solutions collaborate in manufacture of Florbetapir F 18

Avid Radiopharmaceuticals, Inc. and PETNET Solutions, Inc., a wholly-owned subsidiary of Siemens Medical Solutions, USA, Inc., marked the first dose shipped from a PETNET Solutions manufacturing facility as part of its collaboration with Avid on Florbetapir F 18 (18F-AV-45 or Florbetapir), Avid's molecular imaging agent for positron emission tomography (PET) imaging of β-amyloid deposits in the brain, a key pathological component of Alzheimer's disease.

8 Apr 2010

Scientists discover how mechanical stress promotes new bone growth

For osteoporosis patients unable to exercise, help may be on the way. That's because scientists have discovered precisely how mechanical stress, such as exercise, promotes new bone growth. This opens the door to entirely new therapies that can trick bones into thinking they are getting a workout. The research report describing this advance is published online in The FASEB Journal.

8 Apr 2010

Study: New endoscopic spray may offer surgery-free procedure for acute bleeding of peptic ulcers

According to early clinical evidence from a safety study, a new endoscopic spray from Cook Medical may offer a new surgery-free procedure for treating potentially fatal acute bleeding of peptic ulcers.

8 Apr 2010

FDA grants final approval for Teva Pharmaceutical Industries' generic Hyzaar and Cozaar

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).

8 Apr 2010

Torax Medical's LINX Anti-Reflux treatment receives CE Mark approval

Torax Medical Inc., a medical device company focused on the minimally invasive treatment of gastro-esophageal reflux disease (GERD), has received CE Mark for its LINX® Anti-Reflux treatment. The company has started commercial launch of the LINX device at select centers in Europe.

8 Apr 2010

Is grandmother’s age significant to autism?

A report just published in the online journal, PLoS ONE, indicates that the mothers of children with an autistic spectrum disorder were themselves more likely to have been born to older mothers. These findings could open up new avenues in autism research.

8 Apr 2010

King Pharmaceuticals commences Phase IIb clinical trial of ELADUR for chronic low back pain

DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.

7 Apr 2010

Calistoga Pharmaceuticals commences CAL-101 trial in combination with Rituxan and/or Treanda

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.

7 Apr 2010

ASPIRE 2010 focuses on A.R.T. issues

Infertility, defined as the failure to conceive after 12 months or more of regular, unprotected intercourse, may affect as many as 15 percent of couples around the world including Asia. Like other countries, China's infertility rate is on the rise increasing from 3 percent to 15 percent in the past 20 years. It is estimated that at least 40 million Chinese couples have difficulty in having children or are actually infertile.

7 Apr 2010

Updates from Phase I/IIa clinical trial of DIABECELL treatment in insulin-dependent diabetics

Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, today provided a penultimate update regarding the three-year follow up of its Phase I/IIa clinical trial in Russia of its DIABECELL® treatment in insulin-dependent diabetics.

7 Apr 2010

MAP Pharmaceuticals to present additional data from FREEDOM-301 Phase 3 trial of LEVADEX at AAN meeting

MAP Pharmaceuticals, Inc. today announced the Company will present additional post-hoc analyses from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX™ orally inhaled migraine therapy in two patient subpopulations that are often difficult to treat with current triptan migraine therapies: menstrual migraine and migraine with allodynia.

7 Apr 2010

Concerns over safety and effectiveness of "natural" treatments for treating anxiety

In a broad-based review of studies focused on drugs that treat anxiety, a Saint Louis University doctor found no evidence supporting the use of so-called "natural" treatments in combating the effects of anxiety.

7 Apr 2010

Non-conscious, learning systems of the brain simpler and evolutionarily older, study substantiates

A new study from the Swedish medical university Karolinska Institutet provides evidence that basic human learning systems use areas of the brain that also exist in the most primitive vertebrates, such as certain fish, reptiles and amphibians. The study involved an investigation into the limbic striatum, one of the evolutionarily oldest parts of the brain, and the ability to learn movements, consciously and unconsciously, through repetition.

7 Apr 2010

Researchers find small inverse relationship between intake of fruits, vegetables and cancer risk

An analysis by Mount Sinai researchers of over eight years of dietary data from more than 400,000 people has found that the relationship between high consumption of fruits and vegetables and a reduced risk of cancer is not as strong as commonly thought. The study is published online April 6, 2010 in the Journal of the National Cancer Institute.

7 Apr 2010

HOLCOMB C3-R cures bobsledder of impending blindness, helps win gold at 2010 Winter Olympics

It was an amazing triumph of the will, when the U.S. Bobsled Team, led by captain Steve Holcomb, took home the first Gold in 62 years at the 2010 Winter Olympics in Vancouver. An amazing feat, yet only the tip of the iceberg, for 2 years prior Holcomb underwent a brand new procedure to cure his impending blindness.

7 Apr 2010

New seminar series "Physical Care of Duchenne" unveiled

Duchenne Therapy Network today unveiled a new seminar series called, "Physical Care of Duchenne." The course, which includes two separate sessions taught by Jennifer Wallace, PT, will be held at the Ayres Hotel in Costa Mesa.

7 Apr 2010

Medical Condition News

Encouraging results from OptiNose's sumatriptan Phase II study for migraine

Oraya Therapeutics' IRay stereotactic radiotherapy system granted European CE Mark approval

Ultrasound scan of carotid artery improves prediction of heart disease: Research

MAP Pharmaceuticals initiates PD trial comparing LEVADEX to IV DHE

Avid Radiopharmaceuticals, PETNET Solutions collaborate in manufacture of Florbetapir F 18

Scientists discover how mechanical stress promotes new bone growth

Study: New endoscopic spray may offer surgery-free procedure for acute bleeding of peptic ulcers

FDA grants final approval for Teva Pharmaceutical Industries' generic Hyzaar and Cozaar

Torax Medical's LINX Anti-Reflux treatment receives CE Mark approval

Is grandmother’s age significant to autism?

King Pharmaceuticals commences Phase IIb clinical trial of ELADUR for chronic low back pain

Calistoga Pharmaceuticals commences CAL-101 trial in combination with Rituxan and/or Treanda

ASPIRE 2010 focuses on A.R.T. issues

Updates from Phase I/IIa clinical trial of DIABECELL treatment in insulin-dependent diabetics

MAP Pharmaceuticals to present additional data from FREEDOM-301 Phase 3 trial of LEVADEX at AAN meeting

Concerns over safety and effectiveness of "natural" treatments for treating anxiety

Non-conscious, learning systems of the brain simpler and evolutionarily older, study substantiates

Researchers find small inverse relationship between intake of fruits, vegetables and cancer risk

HOLCOMB C3-R cures bobsledder of impending blindness, helps win gold at 2010 Winter Olympics

New seminar series "Physical Care of Duchenne" unveiled

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News